Form 4: Arteris Inc. CFO Nicholas B. Hawkins Sells Shares Under 10b5-1 Trading Plan

Nicholas B. Hawkins, CFO of Arteris, Inc., sold 10,000 shares of common stock at an average price of $8.0067 on May 13, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On May 13, 2024, Nicholas B. Hawkins, the CFO of Arteris, Inc., sold 10,000 shares of the company's common stock.
• The sale was executed under a 10b5-1 trading plan adopted on May 12, 2023.
• The shares were sold at a weighted average price of $8.0067, with individual prices ranging from $7.44 to $8.13.
• Following the transaction, Hawkins directly owns 242,896 shares, which includes 111,519 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company executives are a normal part of corporate governance. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on non-public information.

Comparison to Industry Standards

• Executive stock sales are common across the industry, with many executives using 10b5-1 plans to manage their holdings.
• Comparable companies such as ARM Holdings or Cadence Design Systems also see regular insider trading activity, often disclosed through Form 4 filings.
• The size of the transaction (10,000 shares) is relatively small compared to the total holdings of the reporting person (242,896 shares).

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
• The sale does not directly impact employees, customers, suppliers, or creditors.

Key Dates